Oksidatif Stres; Erektil Disfonksiyonu; Indoleamine 2,3-Dioxygenase Abstract Aim: Indoleamine 2,3-dioxygenase (IDO) is a widely expressed enzyme that cleaves the pyrrole ring from tryptophan by using superoxide anion radicals (O2). Tryptophan metabolite kynurenines have been shown to accelerate apoptosis in endothelial cells. Given that oxidative stress and endothelial dysfunction has been implicated in a pathologic role that results in erectile dysfunction. We aimed here to test the hypothesis that IDO is involved in erectile dysfunction and that the serum IDO level is related to the serum total antioxidant capacity (TAC). Material and Method: Twenty-three erectile dysfunction patients, aged 48±5 years, and 20 age-matched (46±5 years) male controls were included. The total antioxidant capacity (TAC) was assayed in terms of the ferric-reducing ability of plasma (FRAP). Serum IDO levels were determined in duplicate using a commercial double-antibody sandwich technique enzyme-linked immunosorbent assay (ELISA) kit from Sunred Biotechnology Company (Shanghai, China). Results: Serum IDO levels were similar in ED patients 25.7(IQR=37.4) ng/ml compared to the control group 28.0(IQR=63.0) ng/ml (p=0.064). TAC levels were not different in the ED patients 833±189 compared to the control group 921±191μmol/L (p=0.084). Our analysis indicated that IDO level was not correlated with the International Index of Erectile Function (IIEF-5) score (r =0.281, p = 0.067). Discussion: These data suggest that changes in IDO expression are not involved in erectile dysfunction in humans.
Introduction
Erectile dysfunction (ED), the consistent or recurrent failure to achieve an erection for sexual intercourse, affects more than 150 million men worldwide. ED has a prevalence of 69.2% in Turkey [1] . The endothelium plays a crucial role in homeostasis between constricting and relaxing factors involved in erection physiology. Basic science research has led to the conclusion that ED is predominately a disease of vascular origin that endothelial dysfunction plays a major contributing factor [2] , Endothelial dysfunction is characterized by increased endothelial cell apoptosis, impaired endothelium-dependent relaxation, and excessive production of reactive oxygen species (ROS) [2, 3] . ROS are continuously produced intracellularly as a result of cellular metabolism, and steady-state levels mediate many cell functions and cell signaling. In contrast, excessive ROS levels cause damage, and organisms have developed antioxidant systems to reduce this damage. Oxidative stress occurs when cells are exposed to excessive levels of ROS as a result of an imbalance between pro-oxidants and the protective mechanisms conferred by antioxidants [3, 4] . Erectile function is dependent on the relaxation of the cavernous smooth muscle, and its mechanism of action is dependent on penile smooth muscle relaxation mediated by the neurotransmitter nitric oxide (NO), which also is a free radical that forms peroxynitrite with superoxide anions [5] . Oxidative stress has been strongly implicated in the progression of ED, principally through decreasing NO bioavailability and resulting in longterm penile endothelial dysfunction. Under normal physiologic conditions, cavernous endothelial cells are able to detoxify ROS by upregulating the synthesis of antioxidant enzymes when ROS production is increased [6] . Recently, an increasing number of studies have reported the role of the imbalance between the formation of ROS and antioxidant defenses in the pathogenesis of ED [7, 8] . Tryptophan (Trp) is an essential amino acid required for the biosynthesis of key biosynthetic intermediates, such as the neurotransmitter serotonin, the neurohormone melatonin, and niacin. The initial and rate-limiting step of tryptophan catabolism along the kynurenine (Kyn) pathway that yields nicotinamide adenine dinucleotide (NAD) is done by oxidative cleavage of the indole ring by at least one of two structurally different enzymes, either tryptophan 2,3-dioxygenase (TDO) and/or indoleamine 2,3-dioxygenase (IDO). Under physiological conditions, about 99% of Trp is metabolized to Kyn in the liver by TDO, the expression of which is normally restricted to the liver, while the remaining Trp is metabolized by the serotonin pathway [9] . IDO, on the other hand, is a widely expressed enzyme that cleaves the pyrrole ring from tryptophan and other indole-containing compounds by using superoxide anion radicals (O2) as cofactors and substrates in its catalytic process [10] . The potentially pathological roles of Trp metabolites in endothelial cells are largely unknown [11] . In a recent study, kynurenines have been shown to accelerate apoptosis in endothelial cells through induction of NAD(P)H oxidase-derived ROS generation [11] . Given that ROS have been implicated in a pathologic role that results in ED and considering the role of IDO in endothelial cells, we aimed here to test the hypothesis that IDO is involved in ED and that serum IDO levels are related to the serum total antioxidant capacity (TAC).
Material and Method

Study population
Twenty-three ED patients, aged 48±5 years, and 20 agematched (46±5 years old) male controls, selected from hospital staff who had not taken any medication for at least two weeks, were included in this study. The procedures followed were in accordance with the second Declaration of Helsinki. All of the patients and controls gave written informed consent for participation in the study. The study was approved by our Institutional Ethics Committee. Patients with unstable coronary artery disease, congestive cardiac failure, allergy, chronic obstructive pulmonary disease, chronic pulmonary disease, hypertension treated with two or more drugs, currently-prescribed organic nitrate medication, or diabetes, as well as those who had previous pelvic or prostate surgery, were excluded from the study. Venous samples were collected after 12 hours of overnight fasting. The levels of triglyceride (TG), total cholesterol (TChol), HDL cholesterol (HDL-C), BUN, creatinine, and fasting glucose were determined using commercially available assay kits (Abbott Diagnostics, Abbott Park, IL, USA) with an Architect C16000 autoanalyzer (Abbott Diagnostics, Abbott Park, IL, USA). LDL cholesterol (LDL-c) was calculated using the Friedewald et al. formula. The HbA1c level was determined by Adams HA-8160 (Arkray KDK, Shiga, Japan), which uses a cation-exchange HPLC method. The obtained sera were stored at -80 °C until the IDO and TAC assays were performed.
Total Antioxidant Capacity (TAC) Assay
The TAC was assayed in terms of the ferric-reducing ability of plasma (FRAP) [12] . This method measures the ability of antioxidants contained in a sample to reduce ferric tripyridyltriazine (Fe3+-TPTZ) to a ferrous form (Fe2+-TPTZ). The absorbance change was translated into a FRAP value (in μmol/L) by relating the change of absorbance of a test sample to that of a standard solution of known FRAP value.
Measurement of IDO
Serum IDO levels were determined in duplicate using a commercial double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) kit from Sunred Biotechnology Company (Shanghai, China). Forty microliters of serum were added to 40 μl of Streptavidin-HRP, then 10 μl of an IDO antibody solution was added. After incubation for 1 hour at 37 °C, all samples were washed five times with 350 μl of wash solution and next mixed with 100 μl of chromogen solution A and B (1:1, v/v). These mixtures were incubated for a further 10 minutes at 37 °C on an orbital shaker. Fifty μl of 1 M stopping solution was subsequently added. Absorption levels at 450 nm were measured within 15 min, and the amount of IDO in each sample was calculated following the manufacturer's instructions. The results were expressed as nanograms per milliliter. The inter-assay coefficients of variation were <10% and <12% according to the manufacturer's study.
Assessment of erectile dysfunction
All men were asked to complete questions 1-5 of the standardized International Index of Erectile Function-5 (IIEF-5) questionnaire for erectile function assessment, and at the same time were assigned an International Prostate Symptom Score (IPSS). The surveys were analyzed in a blinded fashion [13] .
Statistical Analysis
Statistical analysis was performed with SPSS 21.0 for Windows (SPSS Inc., Chicago, IL). The Shapiro-Wilk test was used to determine the normality of the evaluated variables. Statistically significant differences between parameters with Gaussian distributions were tested by Student's t-test; variables with a nonGaussian distribution were compared using the Mann-Whitney U-test. Variables were evaluated using the Spearman correlation coefficients. Results were expressed as mean SD, and p < 0.05 was considered significant. Table 1 shows the demographic and clinical characteristics of the ED patients and the healthy control group. There were no significant differences about age, BMI, and blood pressure (BP). Table 2 shows the laboratory parameters studied. Serum IDO levels were low in the ED patients (31.09±25.24 ng/ml) compared to the control group (53.86±43.47 ng/ml; p=0.048, MannWhitney U-test). Relative to the control group, the ED patients had slightly higher levels of CRP, glucose, and HbA1c and slightly lower levels of TAC but these differences were not significant (p>0.05) ( Table  2) . Finally, we pooled the data from the ED and control groups to analyze the relationships between erectile function and IDO and TAC (Table 3 ). Our analysis indicated that IDO activity was positively correlated (not significantly though) with IIEF-5 score (r = 0.281, p = 0.067), and no correlation was observed between IDO activity and IPPS values (r = −0.073, p < 0.641). None of the other correlations were statistically significant.
Results
Discussion
We found that serum IDO protein levels were low although not significant in ED patients compared to the control group. An important fact that makes the investigation of IDO relevant is that antioxidants and the cellular redox potential affect IDO activity and expression [10, 14, 15] . IDO activity can be estimated indirectly by the serum kynurenine to tryptophan ratio. However low serum tryptophan levels in case of malnutrition, and decreased renal excretion of kynurenine pathway products, and activity of the liver tryptophan 2,3-dioxygenase may lead to inaccurate results [16] . Thomas et al. showed that structurally and functionally different antioxidants differentially affected the expression of IDO protein [17] . Following synthesis by IDO, Kyn can be further metabolized by various enzymes. Some metabolites, including 3-hydroxykynurenine, are neurotoxic free-radical generators [18] . We could not find a correlation between IDO levels and IIEF-5 scores. The IIEF-5 questionnaire has been accepted as a valid and reliable method of assessing sexual function and distinguishing between men with and without ED [13] . The IIEF-5 questionnaire has been reported to classify the severity of ED properly, so we can speculate that there is no correlation between ED severity and IDO level [13] . TAC is a useful estimate of overall antioxidant status, which may include antioxidants not yet recognized or not easily measured. To assess TAC, several methods are available. The final value of measured TAC in the sample often depends on the procedure used in each specific assay. We measured serum FRAP as a marker of oxidative stress levels in plasma, a method commonly used for TAC measurement [7] . The results of the current study indicate that the antioxidant capacity of sera, determined as a ferric-reducing ability, is low although not significant in ED patients. We found low FRAP levels in ED patients, but we were unable to find a correlation between TAC levels and IDO in these patients. We acknowledge several limitations of this study. First, IDO protein level was measured in serum, which does not necessarily reflect changes occurring in penile endothelial tissue. Secondly, the level of sera FRAP could be significantly influenced by some other factors that we did not take into consideration. Also, a relatively small cohort of patients from a single medical center was enrolled.
Conclusions
In conclusion, these data suggest that changes in serum IDO level may be involved in erectile dysfunction in humans.
